Skip to content

Veritas Aortic Solutions Raises $12M for Non-Surgical Aortic Treatments

Veritas Aortic Solutions has secured $12 million in seed financing to advance its innovative treatment for Root and Ascending Aortic Diseases, specifically through their Transcatheter Valved Aortic Root Conduit (TVARC). The funding, led by MedTech angel investors and Cedars-Sinai, aims to support the clinical development of the TVARC, a non-surgical option designed to improve patient outcomes in high-risk aortic diseases, where current surgical treatments carry significant risks.

COSTA MESA, Calif., June 1, 2026 /PRNewswire/ — Veritas Aortic Solutions, the latest company to spin out of inQB8 Medical Technologies, is pleased to announce the closing of $12M in Seed financing to advance innovative solutions for the treatment of Root and Ascending Aortic Diseases….